ATR inhibition potentiates immunotherapy efficacy via TBK1-NFκB signaling and autophagy blockade in non-small cell lung cancer
Cancer Immunology, Immunotherapy · 01.08.2026 · 75 (11)
DOI: 10.1007/s00262-026-04496-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 01.08.2026. Verfasst von Guo Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin, 300052, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Ataxia Telangiectasia Mutated Proteins, Lung Neoplasms, NF-kappa B. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin, 300052, China.
- Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, 300052, China.
- Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin, 300052, China. dzhong@tmu.edu.cn.
- Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin, 300052, China. zllcaroline@tmu.edu.cn.
ORCID-Profile: Lingping Kong
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, G., Kong, L., Guan, S., Xu, L., Wang, J., Zhong, D., & Zhang, L. (2026). ATR inhibition potentiates immunotherapy efficacy via TBK1-NFκB signaling and autophagy blockade in non-small cell lung cancer. Cancer Immunology, Immunotherapy, 75(11). https://doi.org/10.1007/s00262-026-04496-8
Vancouver
Li G, Kong L, Guan S, Xu L, Wang J, Zhong D, et al. ATR inhibition potentiates immunotherapy efficacy via TBK1-NFκB signaling and autophagy blockade in non-small cell lung cancer. Cancer Immunology, Immunotherapy. 2026;75(11). doi:10.1007/s00262-026-04496-8
BibTeX
@article{Li2026,
author = {Li, Guo and Kong, Lingping and Guan, Shasha and Xu, Lu and Wang, Jing and Zhong, Diansheng and Zhang, Linlin},
title = {ATR inhibition potentiates immunotherapy efficacy via TBK1-NFκB signaling and autophagy blockade in non-small cell lung cancer},
journal = {Cancer Immunology, Immunotherapy},
year = {2026},
volume = {75},
number = {11},
doi = {10.1007/s00262-026-04496-8}
}
EUVIMED